Healthcare Risk & Regulatory Quarterly News Brief

Start adding items to your reading lists:
Sign in
or
Create your account
Save this item to:
This item has been saved to your reading list.

Overview

Our publication designed to highlight recent global compliance, regulatory news and trends.

In this issue: 
  • New Jersey Finalizes “Gift” Ban of Physicians Working with the Pharmaceutical Industry
  • Nevada Releases Guidance for Transparency Legislation
  • Fate of Children's Health Insurance Program (CHIP), ACA Taxes and Fees Uncertain
  • Preparing for GDPR: Is Pharma Ready?
  • State Drug Pricing Legislation Spreads 

Healthcare Risk & Regulatory Quarterly News Brief - February 2018 Download the latest issue

View related documents

 

Related services

 

Related content

The true cost of transparency, transparency movement is accelerating across the global life sciences landscape, with no signs of slowing: PwC

The true cost of transparency

Today the transparency movement is accelerating across the global life sciences landscape, with no signs of slowing.

Start adding items to your reading lists:
Sign in
or
Create your account
Save this item to:
This item has been saved to your reading list.
Pharma Off-Label, On-Label, And Free Speech

Pharma Off-Label, On-Label, And Free Speech

New FDA Guidance: What Does It Mean?

Start adding items to your reading lists:
Sign in
or
Create your account
Save this item to:
This item has been saved to your reading list.

Contact us

Erinn Hutchinson

Principal, PwC US

Linkedin Follow Email
Follow us
Audit and assurance Consulting Tax services Newsroom Alumni US offices Contact us

© 2017 - Fri Feb 26 21:01:07 UTC 2021 PwC. All rights reserved. PwC refers to the US member firm or one of its subsidiaries or affiliates, and may sometimes refer to the PwC network. Each member firm is a separate legal entity. Please see www.pwc.com/structure for further details.